A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension
Clinical trial NCT07700875 · COMPLETED
Trial details
- NCT number
- NCT07700875
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2023-08-20
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.